Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring.
Charalampos MargaritidisEleni KarlaftiEvangelia KotzakioulafiKonstantinos KantartzisKonstantinos TziomalosGeorgia KaiafaChristos SavopoulosTriantafyllos DidangelosPublished in: Journal of clinical medicine (2021)
In well-controlled patients with T2DM, BiAsp30 is an equally effective alternative to PHI.